Avantika Dhabaria
Stock Analyst at Bank of America Securities
(1.98)
# 3,317
Out of 5,108 analysts
14
Total ratings
80%
Success rate
3.7%
Average return
Main Sectors:
Stocks Rated by Avantika Dhabaria
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Reiterated: Buy | n/a | $313.02 | - | 1 | Nov 5, 2026 | |
| STVN Stevanato Group | Reiterated: Buy | n/a | $13.21 | - | 1 | Nov 4, 2026 | |
| WAT Waters | Reiterated: Hold | n/a | $453.08 | - | 2 | Nov 4, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Sell | n/a | $20.46 | - | 2 | Oct 30, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $795 | $676.94 | +17.44% | 3 | Oct 30, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $305 → $320 | $264.88 | +20.81% | 2 | Oct 27, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $190 | $171.78 | +10.61% | 1 | Oct 9, 2026 | |
| MTD Mettler-Toledo International | Reiterated: Buy | $1,690 | $1,679.08 | +0.65% | 1 | Oct 9, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $80 | $58.06 | +37.79% | 1 | Oct 9, 2026 |
Charles River Laboratories International
Nov 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $313.02
Upside: -
Stevanato Group
Nov 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.21
Upside: -
Waters
Nov 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $453.08
Upside: -
Fortrea Holdings
Oct 30, 2026
Reiterated: Sell
Price Target: n/a
Current: $20.46
Upside: -
Thermo Fisher Scientific
Oct 30, 2026
Reiterated: Buy
Price Target: $795
Current: $676.94
Upside: +17.44%
IQVIA Holdings
Oct 27, 2026
Reiterated: Buy
Price Target: $305 → $320
Current: $264.88
Upside: +20.81%
Agilent Technologies
Oct 9, 2026
Reiterated: Buy
Price Target: $190
Current: $171.78
Upside: +10.61%
Mettler-Toledo International
Oct 9, 2026
Reiterated: Buy
Price Target: $1,690
Current: $1,679.08
Upside: +0.65%
10x Genomics
Oct 9, 2026
Reiterated: Hold
Price Target: $80
Current: $58.06
Upside: +37.79%